Professor & Director of Global Health, McGill University
Prof Madhukar Pai, MD, PhD is a Canada Research Chair in Epidemiology & Global Health at McGill University, Montreal. He is the Director of McGill Global Health Programs, and Associate Director of the McGill International TB Centre.
Madhu Pai did his medical training and community medicine residency in Vellore, India. He completed his PhD in epidemiology at UC Berkeley, and a postdoctoral fellowship at the UCSF. Madhu serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on the STAG-TB committee of WHO, Geneva; Scientific Advisory Committee of FIND, Geneva; and Access Advisory Committee of TB Alliance, New York. He has previously served on the Coordinating Board of the Stop TB Partnership. He is on the editorial boards of Lancet Infectious Diseases, PLoS Medicine, PLoS ONE, International Journal of TB and Lung Disease, among others. Madhu’s research is mainly focused on improving the diagnosis and treatment of tuberculosis, especially in high-burden countries like India and South Africa. His research is supported by grant funding from the Gates Foundation, Grand Challenges Canada, and Canadian Institutes of Health Research. He has more than 200 peer-reviewed publications. He is recipient of the Union Scientific Prize, Chanchlani Global Health Research Award, and Haile T. Debas Prize. He is a member of the Royal Society of Canada.
Indian studies show major gaps in TB knowledge and self-reported practices of providers, suggesting poor adherence to established standards in the private sector. A recent study, using simulated patients, confirmed the overall low quality of TB care in the private sector, and revealed a substantial gap between what doctors know and what they actually do in their practice.
Thinking of applying for a postdoctoral fellowship or a training opportunity or even a job? Please read this. Like all researchers at major research-intensive universities, I receive hundreds of emails from candidates looking for potential training opportunities. Very few catch my attention, and very few merit serious consideration. Many emails are poorly written, and most have little to do with my actual line of research. It is frustrating. So, I prepared a list of 10 tips for applicants…
Antimicrobial resistance (AMR) is a global health threat. Since the introduction of antibiotics, microbes have evolved a variety of methods to resist them. We are now dealing with “superbugs” that are virtually untreatable. Drug-resistant tuberculosis (DR-TB) is a prime example of the threat posed by AMR.
As the Prime Minister of India speaks to the US Congress this week, a neglected epidemic threatens India's progress. It's not Ebola or Zika - but rather tuberculosis, an ancient disease that silently kills one Indian every 90 seconds.
As more than half of patients seek care in the private sector, the government needs to engage more with private practitioners and explore innovative ways to do so. They must find ways to ensure that private care providers follow proper diagnostic and treatment protocols, and notify cases to the Revised National Tuberculosis Control Program (RNTCP). Ultimately, TB patients need quality care, regardless of whether they choose to seek care in the public or the private sector.